Sandoz has launched a generic paclitaxel formulation. It is the first generic of Abraxis BioScience’s (a Bristol Myers Squibb Co.) Abraxane to be approved by the Food and Drug Administration. Sandoz ...

ABRAXANE is indicated for the first-line treatment of locally advanced or metastatic non-small cell lung cancer, in combination with carboplatin, in patients who are not candidates for curative ...

NICE does not deem Abraxane more effective than FOLFIRINOX, in addition to the fact that it causes severe side effects. The National Institute for Health and Care Excellence has published new ...

Celgene International Sàrl, a subsidiary of Celgene Corporation (Celgene) (NASDAQ: CELG) today announced that the U.S. Food and Drug Administration (FDA) has assigned a Priority Review designation to ...

It’s not very often you hear about manufacturing problems at Western facilities slammed by Chinese authorities. But it just happened to a key cancer drug that involves three big industry names, ...

Sun Pharma Advanced Research Company Ltd. (SPARC) has announced top-line results of the pivotal BE study for Paclitaxel Injection Concentrate for Suspension (PICS). The pivotal BE study was a ...